Categories AlphaGraphs, Earnings, Health Care

Cigna stock rises on upbeat Q3 results

Cigna Corp. (CI) reported a 38% jump in earnings for the third quarter as continued strong business growth in its Global Health Care and Global Supplemental Benefits segments drove revenues higher. The results exceeded analysts’ expectations. Following this, the stock inched up over 3% in the premarket session.

Shareholders’ net income climbed 38% to $772 million or $3.14 per share. Adjusted income from operations jumped 35% to $945 million or $3.84 per share on continued strong contributions from each of its growth platforms.

Cigna third quarter 2018 Earnings Infographic
Cigna Q3 2018 Earnings Infographics

Continued strong business growth in Cigna’s Global Health Care and Global Supplemental Benefits segments drove total revenues higher by 9% to $11.5 billion.

Global Health Care revenues increased 12% year-over-year on Commercial customer growth and expansion of specialty relationships as well as premium rises consistent with underlying cost trends. Cigna’s medical customer base at the end of the third quarter rose by 363,000 to 16.3 million on continued organic growth in Select, Middle Market, and Individual segments.

Global Supplemental Benefits revenues grew 11% on continued business growth in its targeted markets with the further expansion of customer relationships through continued innovation in product design and distribution strategies. Revenue from Group Disability and Life rose by 2% on continued solid performance in both disability and life businesses.

Looking ahead into the full year 2018, the company now expects total revenues growth of about 8.5% and adjusted income from operations in the range of $14.20 to $14.40 per share. Global Medical customer growth is predicted to be 400,000 to 500,000 customers. The per share outlook excludes the impact of additional prior year reserve development and the potential effects of any future capital deployment.

Express Scripts Q3 profit jumps 27%, meets estimates

For 2019, Cigna expects to continue driving innovation, growth, and value, all of which will be further enhanced through its pending combination with Express Scripts Holding Corp (ESRX).

Shares of Cigna ended Wednesday’s regular session up 1.70% at $213.81 on the NYSE. The stock has risen over 8% in the past year and over 5% since the beginning of the year.


Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Viewing Highlight